BIOMAT Database Logo BIOMAT Database Logo

[Effect of anti-arrhythmia treatment on systemic hemodynamics in patients with a tachysystolic variant of auricular fibrillation]. 1982

L P Vorob'ev, and A N Kaziulin

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations

Related Publications

L P Vorob'ev, and A N Kaziulin
[Treatment of complete arrhythmia: auricular fibrillation].
January 1966, Prensa medica argentina,
L P Vorob'ev, and A N Kaziulin
[Value of anti-arrhythmia treatment after correction of stable auricular fibrillation].
February 1981, Klinicheskaia meditsina,
L P Vorob'ev, and A N Kaziulin
[Characteristics of hemodynamics in the tachysystolic form of atrial fibrillation].
January 1984, Terapevticheskii arkhiv,
L P Vorob'ev, and A N Kaziulin
[Regulation of auricular fibrillation with mitral valve disease; effect of exercise on hemodynamics].
July 1959, Nordisk medicin,
L P Vorob'ev, and A N Kaziulin
[Hemodynamics of the auricular fibrillation].
January 1963, Niigata Igakkai zasshi. Niigata medical journal,
L P Vorob'ev, and A N Kaziulin
[Immediate effect of electroimpulse therapy on the indicators of hemodynamics and myocardial contractility in patients with auricular fibrillation].
January 1976, Terapevticheskii arkhiv,
L P Vorob'ev, and A N Kaziulin
[Risks and complications in treatment of arrhythmia due to auricular fibrillation].
April 1972, La Vie medicale au Canada francais,
L P Vorob'ev, and A N Kaziulin
[Effect of lidoflazine on auricular arrhythmia].
October 1977, La Nouvelle presse medicale,
L P Vorob'ev, and A N Kaziulin
[Effect of a new anti-arrhythmia drug allapinin on hemodynamics in patients with a persistent form of atrial fibrillation before and after restoration of sinus rhythm].
April 1990, Kardiologiia,
L P Vorob'ev, and A N Kaziulin
[Auricular fibrillation, systemic embolism and anticoagulant treatment].
June 1993, Revista medica de Chile,
Copied contents to your clipboard!